Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heyman, A.
Right arrow Articles by Pieper, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heyman, A.
Right arrow Articles by Pieper, C.
Neurology 1999;52:1839
© 1999 American Academy of Neurology


Articles

Comparison of Lewy body variant of Alzheimer’s disease with pure Alzheimer’s disease

Consortium to Establish a Registry for Alzheimer’s Disease, Part XIX

A. Heyman, MD, G. G. Fillenbaum, PhD, M. Gearing, PhD, S. S. Mirra, MD, K. A. Welsh-Bohmer, PhD, B. Peterson, PhD and C. Pieper, DrPH

From the Division of Neurology (Dr. Heyman), the Center for the Study of Aging and Human Development (Drs. Fillenbaum and Welsh-Bohmer), and the Division of Biometry (Drs. Peterson and Pieper), Duke University, Durham, NC; the Department of Pathology and Laboratory Medicine (Dr. Gearing), Emory University, Atlanta, GA; and the Department of Pathology (Dr. Mirra), State University of New York Health Science Center, Brooklyn, NY.

Address correspondence and reprint requests to Dr. A. Heyman, Box 3203 DUMC, Durham, NC 27710.

OBJECTIVE: To compare the clinical, neuropsychological, and neuropathologic findings in patients with AD alone with those in patients with the Lewy body variant of AD (LBV).

BACKGROUND: Prior studies indicate that patients with LBV not only have distinct clinical and neuropsychological differences from those with AD alone, but have a poorer prognosis with shorter survival time.

METHODS: The authors evaluated 74 patients with autopsy-confirmed AD alone and 27 patients with LBV, and compared demographic characteristics and clinical, neuropsychological, and neuropathologic findings.

RESULTS: The two groups of patients were equivalent with respect to age at time of entry into the study, years of education, and sex. Two or more extrapyramidal clinical manifestations were found in 44% of patients with LBV, compared with 16% of patients with AD alone (p = 0.02). Duration of survival after entry into the study was similar in both groups, with a mean survival of 3.6 (±2.1) years for AD alone versus 3.8 (±1.9) years for LBV. Of the various neuropsychological tests administered at the last Consortium to Establish a Registry for Alzheimer’s Disease evaluation, only delayed recall of a learned word list was significantly different in the two groups, with 32% of patients with LBV versus 15% of patients with AD alone recalling any items (p = 0.04). Neuropathologic findings confirmed those of previous studies and showed that neurofibrillary tangles were significantly less frequent in the neocortex of patients with LBV than in those with AD alone.

CONCLUSION: Compared with patients with AD alone, those with LBV had a greater frequency of extrapyramidal manifestations, somewhat better recall on a selected memory task at their final evaluation, and a significantly lower frequency of neocortical neurofibrillary tangles at autopsy. There were no differences between the two groups, however, in survival time from entry into the study.




This article has been cited by other articles:


Home page
Arch NeurolHome page
A. Nervi, C. Reitz, M.-X. Tang, V. Santana, A. Piriz, D. Reyes-Dumeyer, R. Lantigua, M. Medrano, I. Z. Jimenez-Velazquez, J. H. Lee, et al.
Comparison of Clinical Manifestations in Alzheimer Disease and Dementia With Lewy Bodies
Arch Neurol, December 1, 2008; 65(12): 1634 - 1639.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
E. D. Louis, P. L. Faust, J.-P. G. Vonsattel, L. S. Honig, A. Rajput, C. A. Robinson, A. Rajput, R. Pahwa, K. E. Lyons, G.W. Ross, et al.
Neuropathological changes in essential tremor: 33 cases compared with 21 controls
Brain, December 1, 2007; 130(12): 3297 - 3307.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
D. Tsuang, K. Simpson, E. B. Larson, E. Peskind, W. Kukull, J. B. Bowen, W. McCormick, L. Teri, T. Montine, M. L. Thompson, et al.
Predicting lewy body pathology in a community-based sample with clinical diagnosis of Alzheimer's disease.
J Geriatr Psychiatry Neurol, December 1, 2006; 19(4): 195 - 201.
[Abstract] [PDF]


Home page
Arch NeurolHome page
K. Stavitsky, A. M. Brickman, N. Scarmeas, R. L. Torgan, M.-X. Tang, M. Albert, J. Brandt, D. Blacker, and Y. Stern
The progression of cognition, psychiatric symptoms, and functional abilities in dementia with lewy bodies and Alzheimer disease.
Arch Neurol, October 1, 2006; 63(10): 1450 - 1456.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
R. Holtzer, M. C. Irizarry, J. Sanders, B. T. Hyman, D. J. Wegesin, A. Riba, J. Brandt, M. Albert, and Y. Stern
Relation of Quantitative Indexes of Concurrent {alpha}-Synuclein Abnormalities to Clinical Outcome in Autopsy-Proven Alzheimer Disease
Arch Neurol, February 1, 2006; 63(2): 226 - 230.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. L. Kraybill, E. B. Larson, D. W. Tsuang, L. Teri, W. C. McCormick, J. D. Bowen, W. A. Kukull, J. B. Leverenz, and M. M. Cherrier
Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both
Neurology, June 28, 2005; 64(12): 2069 - 2073.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. Scarmeas, M. Albert, J. Brandt, D. Blacker, G. Hadjigeorgiou, A. Papadimitriou, B. Dubois, M. Sarazin, D. Wegesin, K. Marder, et al.
Motor signs predict poor outcomes in Alzheimer disease
Neurology, May 24, 2005; 64(10): 1696 - 1703.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. M. Burns, J. E. Galvin, C. M. Roe, J. C. Morris, and D. W. McKeel
The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs
Neurology, April 26, 2005; 64(8): 1397 - 1403.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. W. Tsuang, R. K. Wilson, O. L. Lopez, E. K. Luedecking-Zimmer, J. B. Leverenz, S. T. DeKosky, M. I. Kamboh, and R. L. Hamilton
Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease
Neurology, February 8, 2005; 64(3): 509 - 513.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. Scarmeas, G. M. Hadjigeorgiou, A. Papadimitriou, B. Dubois, M. Sarazin, J. Brandt, M. Albert, K. Marder, K. Bell, L. S. Honig, et al.
Motor signs during the course of Alzheimer disease
Neurology, September 28, 2004; 63(6): 975 - 982.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
C. G. Ballard, R. Jacoby, T. Del Ser, M. N. Khan, D. G. Munoz, C. Holmes, Z. Nagy, E. K. Perry, C. Joachim, E. Jaros, et al.
Neuropathological Substrates of Psychiatric Symptoms in Prospectively Studied Patients With Autopsy-Confirmed Dementia With Lewy Bodies
Am J Psychiatry, May 1, 2004; 161(5): 843 - 849.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
D. S. Knopman, B. F. Boeve, and R. C. Petersen
Essentials of the Proper Diagnoses of Mild Cognitive Impairment, Dementia, and Major Subtypes of Dementia
Mayo Clin. Proc., October 1, 2003; 78(10): 1290 - 1308.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J Lindeboom, B Schmand, L Tulner, G Walstra, and C Jonker
Visual association test to detect early dementia of the Alzheimer type
J. Neurol. Neurosurg. Psychiatry, August 1, 2002; 73(2): 126 - 133.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. N. Haan, W. J. Jagust, D. Galasko, and J. Kaye
Effect of Extrapyramidal Signs and Lewy Bodies on Survival in Patients With Alzheimer Disease
Arch Neurol, April 1, 2002; 59(4): 588 - 593.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Della Sala, O Turnbull, N Beschin, M Perini, and T A Ala
Orientation agnosia in pentagon copying
J. Neurol. Neurosurg. Psychiatry, January 1, 2002; 72(1): 129 - 130.
[Full Text] [PDF]


Home page
Arch NeurolHome page
H. Apaydin, J. E. Ahlskog, J. E. Parisi, B. F. Boeve, and D. W. Dickson
Parkinson Disease Neuropathology: Later-Developing Dementia and Loss of the Levodopa Response
Arch Neurol, January 1, 2002; 59(1): 102 - 112.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H J Tschampa, M Neumann, I Zerr, K Henkel, A Schroter, W J Schulz-Schaeffer, B J Steinhoff, H A Kretzschmar, and S Poser
Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease
J. Neurol. Neurosurg. Psychiatry, July 1, 2001; 71(1): 33 - 39.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. S. Knopman, S. T. DeKosky, J. L. Cummings, H. Chui, J. Corey-Bloom, N. Relkin, G. W. Small, B. Miller, and J. C. Stevens
Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurology, May 8, 2001; 56(9): 1143 - 1153.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
T A Ala, L F Hughes, G A Kyrouac, M W Ghobrial, and R J Elble
Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, April 1, 2001; 70(4): 483 - 488.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
Y. Stern, D. Jacobs, J. Goldman, E. Gomez-Tortosa, B. T. Hyman, Y. Liu, J. Troncoso, K. Marder, M. X. Tang, J. Brandt, et al.
An Investigation of Clinical Correlates of Lewy Bodies in Autopsy-Proven Alzheimer Disease
Arch Neurol, March 1, 2001; 58(3): 460 - 465.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
L. S. Honig
Inflammation in Neurodegenerative Disease: Good, Bad, or Irrelevant?
Arch Neurol, June 1, 2000; 57(6): 786 - 788.
[Full Text] [PDF]


Home page
NeurologyHome page
O. L. Lopez, S. Wisniewski, R. L. Hamilton, J. T. Becker, D. I. Kaufer, and S. T. DeKosky
Predictors of progression in patients with AD and Lewy bodies
Neurology, May 9, 2000; 54(9): 1774 - 1779.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
O. L. Lopez, R. L. Hamilton, J. T. Becker, S. Wisniewski, D. I. Kaufer, and S. T. DeKosky
Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies
Neurology, May 9, 2000; 54(9): 1780 - 1787.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. Tiraboschi, L. A. Hansen, M. Alford, M. N. Sabbagh, B. Schoos, E. Masliah, L. J. Thal, and J. Corey-Bloom
Cholinergic dysfunction in diseases with Lewy bodies
Neurology, January 25, 2000; 54(2): 407 - 407.
[Abstract] [Full Text] [PDF]


Home page
JWatch NeurologyHome page
Lewy Body Variant of Alzheimer's Disease
Journal Watch Neurology, November 1, 1999; 1999(1101): 8 - 8.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by AAN Enterprises, Inc.